Aroda, MD, Director of Diabetes Clinical Research at Brigham and Womens Hospital and Associate Professor of Medicine at Harvard Medical School
Includes basic HIPAA-compliant video, simple intake forms, and manual pharmacy coordination
however, establishing it as a potential lead peptide agonist of GLP-1R requires further experimental evaluations
N Engl J Med 358:25452559 Ross SA, Brown JC, Dupr J (1997) Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus
compounded formulations can be adjusted to account for faster or slower hepatic clearance, delivering more consistent serum levels throughout your injection cycle
10.1016/j.molmet.2018.03.004 238